Ryan Specialty Company Leadership
RYAN Stock | USD 65.61 0.43 0.65% |
About 95 percent of Ryan Specialty's insiders are activelly selling. The analysis of insiders' sentiment of trading Ryan Specialty Group stock suggests that quite a large number of insiders are panicking at this time. Ryan Specialty employs about 5.6 K people. The company is managed by 36 executives with a total tenure of roughly 60 years, averaging almost 1.0 years of service per executive, having 154.33 employees per reported executive.
Insider Sentiment 5
Mostly Selling
Selling | Buying |
Latest Trades
2025-06-13 | Mark Stephen Katz | Disposed 14377 @ 65.84 | View | ||
2025-06-03 | David P Bolger | Disposed 5000 @ 70.8 | View | ||
2025-03-14 | Brendan Martin Mulshine | Disposed 30000 @ 69.3 | View | ||
2025-01-29 | Nicholas Dominic Cortezi | Disposed 31409 @ 65.64 | View | ||
2025-01-27 | Nicholas Dominic Cortezi | Disposed 35000 @ 65.25 | View | ||
2025-01-23 | Nicholas Dominic Cortezi | Disposed 10485 @ 65.12 | View | ||
2025-01-21 | Nicholas Dominic Cortezi | Disposed 35000 @ 66.35 | View | ||
2025-01-17 | Nicholas Dominic Cortezi | Disposed 35000 @ 67.15 | View | ||
2025-01-15 | Nicholas Dominic Cortezi | Disposed 35000 @ 65.99 | View | ||
2025-01-13 | Nicholas Dominic Cortezi | Disposed 29466 @ 65.06 | View | ||
2024-12-20 | Nicholas Dominic Cortezi | Disposed 91 @ 65 | View | ||
2024-12-18 | Nicholas Dominic Cortezi | Disposed 35000 @ 65.17 | View | ||
2024-12-16 | Nicholas Dominic Cortezi | Disposed 35000 @ 66.71 | View | ||
2024-12-13 | Nicholas Dominic Cortezi | Disposed 35000 @ 67.39 | View | ||
2024-11-21 | David P Bolger | Disposed 7055 @ 70.88 | View | ||
2024-11-08 | Mark Stephen Katz | Disposed 14790 @ 71.39 | View | ||
2024-11-05 | Patrick G Ryan Jr | Acquired 100 @ 68.72 | View | ||
2024-08-28 | Nicholas Dominic Cortezi | Disposed 5375 @ 64.73 | View | ||
2024-08-26 | Nicholas Dominic Cortezi | Disposed 2325 @ 64.6 | View | ||
2024-08-23 | Nicholas Dominic Cortezi | Disposed 1703 @ 64.66 | View |
Monitoring Ryan Specialty's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Ryan Specialty Management Team Effectiveness
The company has return on total asset (ROA) of 0.0368 % which means that it generated a profit of $0.0368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1819 %, meaning that it created $0.1819 on every $100 dollars invested by stockholders. Ryan Specialty's management efficiency ratios could be used to measure how well Ryan Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ryan Specialty's Return On Tangible Assets are very stable compared to the past year. As of the 21st of July 2025, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop 0.04. At this time, Ryan Specialty's Return On Assets are very stable compared to the past year. As of the 21st of July 2025, Asset Turnover is likely to grow to 0.31, while Total Assets are likely to drop about 6.5 B.As of the 21st of July 2025, Common Stock Shares Outstanding is likely to drop to about 208.6 M. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 50 M
Ryan Specialty Workforce Comparison
Ryan Specialty Group is currently regarded as top stock in number of employees category among its peers. The total workforce of Financials industry is at this time estimated at about 34,404. Ryan Specialty retains roughly 5,556 in number of employees claiming about 16% of equities under Financials industry.
Ryan Specialty Profit Margins
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.28 | 0.3675 |
|
| |||||
Net Profit Margin | 0.0657 | 0.0376 |
|
| |||||
Operating Profit Margin | 0.088 | 0.1701 |
|
| |||||
Pretax Profit Margin | 0.0715 | 0.1083 |
|
| |||||
Return On Assets | 0.0184 | 0.0098 |
|
|
Ryan Specialty Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ryan Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ryan Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Ryan Specialty insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-06-01 | 0.95 | 19 | 20 | 96,141 | 193,040 |
2025-03-01 | 0.0645 | 2 | 31 | 30,075 | 449,909 |
2024-12-01 | 0.2 | 5 | 25 | 30,040 | 866,570 |
2024-09-01 | 0.1667 | 7 | 42 | 2,769,317 | 7,795,261 |
2024-06-01 | 1.7778 | 16 | 9 | 37,224 | 19,398 |
2024-03-01 | 1.0 | 1 | 1 | 38,182 | 0.00 |
2023-09-01 | 0.215 | 23 | 107 | 477,222 | 2,289,769 |
2023-06-01 | 0.375 | 33 | 88 | 1,030,816 | 11,907,236 |
2023-03-01 | 1.6667 | 5 | 3 | 387,374 | 135,000 |
2022-09-01 | 0.3333 | 1 | 3 | 11,531 | 33,562 |
2022-06-01 | 2.6667 | 8 | 3 | 22,632 | 733,497 |
2021-09-01 | 0.5946 | 22 | 37 | 22,956,086 | 38,712,830 |
2004-12-01 | 0.25 | 1 | 4 | 45,300 | 90,600 |
2004-09-01 | 0.5 | 1 | 2 | 2,250 | 4,500 |
2004-06-01 | 0.2 | 1 | 5 | 60,000 | 154,000 |
2004-03-01 | 0.2857 | 2 | 7 | 74,700 | 170,270 |
2003-12-01 | 0.625 | 5 | 8 | 105,625 | 133,560 |
2003-09-01 | 0.2 | 1 | 5 | 45,000 | 135,605 |
Ryan Specialty Notable Stakeholders
A Ryan Specialty stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ryan Specialty often face trade-offs trying to please all of them. Ryan Specialty's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ryan Specialty's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Catherine Gill | CEO LifeScienceRisk | Profile | |
Emil Issavi | CEO Managers | Profile | |
Patrick Ryan | Chairman of the Board of Directors, Chief Executive Officer, Founder | Profile | |
Timothy Turner | President, Director, Chairman and Chief Executive Officer of RT Specialty | Profile | |
Michael Vanacker | Chief Operating Officer, Executive Vice President | Profile | |
Jeremiah Bickham | Chief Financial Officer, Executive Vice President | Profile | |
Eric Quinn | President | Profile | |
Kieran Dempsey | EVP Officer | Profile | |
Nicholas CFA | Director Relations | Profile | |
Mark Esq | General VP | Profile | |
Alice Topping | Chief Officer | Profile | |
Brendan Mulshine | Executive Vice President Chief Revenue Officer | Profile | |
Kirk Behrens | Technology Operations | Profile | |
Stephen Keogh | Chief Officer | Profile | |
Lisa Paschal | Chief Human Resources Officer, Senior Vice President | Profile | |
Dawn DOnofrio | Executive Segment | Profile | |
Michael Ohalleran | Director | Profile | |
David Bolger | Independent Director | Profile | |
Michael Conklin | Executive Officer | Profile | |
John Rogers | Independent Director | Profile | |
Anthony Hanes | LLC Funding | Profile | |
Mark Melander | Chief Officer | Profile | |
Andrew McKenna | Independent Director | Profile | |
Benjamin Wuller | Chief Managers | Profile | |
Robert Blanc | Independent Director | Profile | |
Bradley BS | Chief Officer | Profile | |
William Devers | Independent Director | Profile | |
Nicholas Cortezi | Chairman - RSG Underwriting Managers | Profile | |
Henry Bienen | Independent Director | Profile | |
Mark Katz | Executive Vice President General Counsel | Profile | |
Noah Angeletti | Treasurer Relations | Profile | |
Michael Schulz | Senior Controller | Profile | |
Janice Hamilton | Chief Controller | Profile | |
Michael Blackshear | Chief VP | Profile | |
Jamie Bouloux | Chief Lines | Profile | |
D Findlay | Independent Director | Profile |
About Ryan Specialty Management Performance
The success or failure of an entity such as Ryan Specialty Group often depends on how effective the management is. Ryan Specialty management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ryan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ryan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.01 | 0.03 | |
Return On Capital Employed | 0.04 | 0.04 | |
Return On Assets | 0.01 | 0.02 | |
Return On Equity | 0.15 | 0.12 |
Ryan Specialty Workforce Analysis
Traditionally, organizations such as Ryan Specialty use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ryan Specialty within its industry.Ryan Specialty Manpower Efficiency
Return on Ryan Specialty Manpower
Revenue Per Employee | 452.8K | |
Revenue Per Executive | 69.9M | |
Net Income Per Employee | 41.4K | |
Net Income Per Executive | 6.4M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.39 | Dividend Share 0.45 | Earnings Share 0.36 | Revenue Per Share | Quarterly Revenue Growth 0.257 |
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ryan Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.